BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,527,717 | +298.4% | 780,751 | +296.2% | 0.01% | +250.0% |
| Q2 2023 | $1,387,436 | +311.3% | 197,079 | +387.3% | 0.00% | -20.0% |
| Q1 2023 | $337,303 | -95.7% | 40,444 | -94.1% | 0.01% | -96.5% |
| Q4 2022 | $7,826,295 | +86.7% | 681,733 | +104.8% | 0.14% | +78.8% |
| Q3 2022 | $4,193,000 | +564.5% | 332,814 | +458.4% | 0.08% | +370.6% |
| Q2 2022 | $631,000 | -78.7% | 59,598 | -67.4% | 0.02% | -78.5% |
| Q1 2022 | $2,969,000 | +402.4% | 182,567 | +343.9% | 0.08% | +364.7% |
| Q3 2021 | $591,000 | +167.4% | 41,131 | +194.7% | 0.02% | +112.5% |
| Q2 2021 | $221,000 | -29.4% | 13,958 | -91.1% | 0.01% | -88.4% |
| Q1 2020 | $313,000 | -12.3% | 156,507 | +51.4% | 0.07% | +200.0% |
| Q4 2019 | $357,000 | – | 103,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |